Year |
Citation |
Score |
2008 |
Rajasekaran SA, Christiansen JJ, Schmid I, Oshima E, Ryazantsev S, Sakamoto K, Weinstein J, Rao NP, Rajasekaran AK. Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability. Molecular Cancer Therapeutics. 7: 2142-51. PMID 18645024 DOI: 10.1158/1535-7163.Mct-08-0005 |
0.754 |
|
2007 |
Pelling AE, Dawson DW, Carreon DM, Christiansen JJ, Shen RR, Teitell MA, Gimzewski JK. Distinct contributions of microtubule subtypes to cell membrane shape and stability. Nanomedicine : Nanotechnology, Biology, and Medicine. 3: 43-52. PMID 17379168 DOI: 10.1016/J.Nano.2006.11.006 |
0.406 |
|
2007 |
Barwe SP, Maul RS, Christiansen JJ, Anilkumar G, Cooper CR, Kohn DB, Rajasekaran AK. Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix. International Journal of Oncology. 30: 899-904. PMID 17332929 DOI: 10.3892/Ijo.30.4.899 |
0.742 |
|
2006 |
Christiansen JJ, Weimbs T, Bander N, Rajasekaran AK. Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE-mediated apical targeting of prostate-specific membrane antigen. Molecular Cancer Therapeutics. 5: 2468-73. PMID 17041090 DOI: 10.1158/1535-7163.Mct-06-0253 |
0.747 |
|
2006 |
Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research. 66: 8319-26. PMID 16951136 DOI: 10.1158/0008-5472.Can-06-0410 |
0.57 |
|
2006 |
Anilkumar G, Barwe SP, Christiansen JJ, Rajasekaran SA, Kohn DB, Rajasekaran AK. Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature. Microvascular Research. 72: 54-61. PMID 16713605 DOI: 10.1016/J.Mvr.2006.03.004 |
0.761 |
|
2005 |
Christiansen JJ, Rajasekaran SA, Inge L, Cheng L, Anilkumar G, Bander NH, Rajasekaran AK. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Molecular Cancer Therapeutics. 4: 704-14. PMID 15897234 DOI: 10.1158/1535-7163.Mct-04-0171 |
0.716 |
|
2005 |
Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? American Journal of Physiology. Cell Physiology. 288: C975-81. PMID 15840561 DOI: 10.1152/Ajpcell.00506.2004 |
0.757 |
|
2004 |
Christiansen J, Rajasekaran AK. Biological impediments to monoclonal antibody-based cancer immunotherapy. Molecular Cancer Therapeutics. 3: 1493-501. PMID 15542788 |
0.598 |
|
2003 |
Christiansen JJ, Rajasekaran SA, Moy P, Butch A, Goodglick L, Gu Z, Reiter RE, Bander NH, Rajasekaran AK. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. The Prostate. 55: 9-19. PMID 12640656 DOI: 10.1002/Pros.10203 |
0.744 |
|
Show low-probability matches. |